Literature DB >> 30087051

A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers.

Pim B Olthof1, Mamoru Miyasaka2, Bas Groot Koerkamp3, Jimme K Wiggers4, William R Jarnagin5, Takehiro Noji2, Satoshi Hirano2, Thomas M van Gulik6.   

Abstract

BACKGROUND: Perihilar cholangiocarcinoma (PHC) often requires extensive surgery which is associated with substantial morbidity and mortality. This study aimed to compare an Eastern and Western PHC cohort in terms of patient characteristics, treatment strategies and outcomes including a propensity score matched analysis.
METHODS: All consecutive patients who underwent combined biliary and liver resection for PHC between 2005 and 2016 at two Western and one Eastern center were included. The overall perioperative and long-term outcomes of the cohorts were compared and a propensity score matched analysis was performed to compare perioperative outcomes.
RESULTS: A total of 210 Western patients were compared to 164 Eastern patients. Western patients had inferior survival compared to the East (hazard-ratio 1.72 (1-23-2.40) P < 0.001) corrected for age, ASA score, tumor stage and margin status. After propensity score matching, liver failure rate, morbidity, and mortality were similar. There was more biliary leakage (38% versus 13%, p = 0.015) in the West.
CONCLUSION: There were major differences in patient characteristics, treatment strategies, perioperative outcomes and survival between Eastern and Western PHC cohorts. Future studies should focus whether these findings are due to the differences in the treatment or the disease itself.
Copyright © 2018 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30087051     DOI: 10.1016/j.hpb.2018.07.014

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  13 in total

1.  Authors' Reply: Routine Pathology and Postoperative Follow-Up are not Cost-Effective in Cholecystectomy for Benign Gallbladder Disease.

Authors:  Pim B Olthof; Madelon M E Metman; Daphne Roos; Jan Willem T Dekker
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

2.  Transhepatic Direct Approach to the "Limit of the Division of the Hepatic Ducts" Leads to a High R0 Resection Rate in Perihilar Cholangiocarcinoma.

Authors:  Takehiro Noji; Kimitaka Tanaka; Aya Matsui; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Satoshi Hirano
Journal:  J Gastrointest Surg       Date:  2021-01-05       Impact factor: 3.452

3.  Editorial on "Perihilar Cholangiocarcinoma-Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers".

Authors:  Shivan Sivakumar; Flavio G Rocha; Lara Heij
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

4.  Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma.

Authors:  Takehiro Noji; Satoko Uemura; Jimme K Wiggers; Kimitaka Tanaka; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Pim B Olthof; William R Jarnagin; Thomas M van Gulik; Satoshi Hirano
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

5.  Surgical outcomes of perihilar cholangiocarcinoma based on the learning curve of a single surgeon at a tertiary academic hospital: A retrospective study.

Authors:  Hye Jeong Park; Dai Hoon Han; Gi Hong Choi; Jin Sub Choi
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-02-28

Review 6.  The Landmark Series: Hilar Cholangiocarcinoma.

Authors:  Kevin C Soares; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2021-04-07       Impact factor: 4.339

7.  Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma.

Authors:  Pim B Olthof; Luca Aldrighetti; Ruslan Alikhanov; Matteo Cescon; Bas Groot Koerkamp; William R Jarnagin; Silvio Nadalin; Johann Pratschke; Moritz Schmelze; Ernesto Sparrelid; Hauke Lang; Alfredo Guglielmi; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2020-02-26       Impact factor: 5.344

8.  ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.

Authors:  Pim B Olthof; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2020-03-09       Impact factor: 5.344

Review 9.  Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma.

Authors:  Daniele Dondossola; Michele Ghidini; Francesco Grossi; Giorgio Rossi; Diego Foschi
Journal:  World J Gastroenterol       Date:  2020-07-07       Impact factor: 5.742

10.  Effect of structured use of preoperative portal vein embolization on outcomes after liver resection of perihilar cholangiocarcinoma.

Authors:  L C Franken; F Rassam; K P van Lienden; R J Bennink; M G Besselink; O R Busch; J I Erdmann; T M van Gulik; P B Olthof
Journal:  BJS Open       Date:  2020-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.